Clinuvel Pharmaceuticals Limited (CUVL)
NASDAQ: CUVL · Real-Time Price · USD
7.80
0.00 (0.00%)
Aug 21, 2026, 4:00 PM EDT - Market closed
Clinuvel Pharmaceuticals Market Cap
Clinuvel Pharmaceuticals has a market cap or net worth of $376.65 million as of August 21, 2026.
Market Cap
376.65M
Enterprise Value
209.87M
1-Year Change
n/a
Ranking
Category
Stock Price
$7.80
ChartMarket Cap Chart
Since July 20, 2026, Clinuvel Pharmaceuticals's market cap has increased from $371.50M to $376.65M, an increase of 1.39%. That is a compound annual growth rate of 17.58%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 20, 2026 | 391.60M | 9.11% |
| Aug 19, 2026 | 358.90M | 3.61% |
| Aug 18, 2026 | 346.40M | 0.38% |
| Aug 17, 2026 | 345.10M | -0.38% |
| Aug 14, 2026 | 346.40M | 2.61% |
| Aug 13, 2026 | 337.60M | 0.69% |
| Aug 12, 2026 | 335.30M | -2.64% |
| Aug 11, 2026 | 344.40M | 1.77% |
| Aug 10, 2026 | 338.40M | 0.92% |
| Aug 7, 2026 | 335.30M | -0.65% |
| Aug 6, 2026 | 337.50M | 3.37% |
| Aug 5, 2026 | 326.50M | -4.92% |
| Aug 4, 2026 | 343.40M | -1.44% |
| Aug 3, 2026 | 348.40M | 6.94% |
| Jul 31, 2026 | 325.80M | -6.35% |
| Jul 30, 2026 | 347.90M | 1.55% |
| Jul 29, 2026 | 342.60M | -2.64% |
| Jul 28, 2026 | 351.90M | - |
| Jul 27, 2026 | 351.90M | 0.86% |
| Jul 24, 2026 | 348.90M | - |
| Jul 23, 2026 | 348.90M | -0.71% |
| Jul 22, 2026 | 351.40M | -0.28% |
| Jul 21, 2026 | 352.40M | -5.14% |
| Jul 20, 2026 | 371.50M | - |
View and export this data all the way back to 2026. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Rocket Pharmaceuticals | 400.68M |
| Enanta Pharmaceuticals | 393.48M |
| Lyell Immunopharma | 386.20M |
| Century Therapeutics | 382.07M |
| Palisade Bio | 376.42M |
| Agenus | 371.87M |
| Galectin Therapeutics | 370.12M |
| DiaMedica Therapeutics | 367.23M |